Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1036 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

FDA approves Lupin Tramadol HCl ER Tablets ANDA

Tramadol HCl ER is a centrally acting synthetic analgesic in an extended release formulation. Tramadol HCl ER is generic equivalent to Ultram ER Tablets of Ortho-McNeil-Janssen Pharmaceuticals which

Greenway launches remote clinic PrimeMobile

PrimeMobile incorporates functionality accessed on handheld devices with Greenway’s single-database electronic health record (EHR), practice management and interoperability solution – PrimeSuite. PrimeMobile’s administrative and financial capabilities integrate charge

Eisai reports seizure drug study results

Perampanel is an orally administered, highly selective non-competitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptor antagonist discovered and being developed by Eisai. In Study 305, the response rates (defined as

Sinclair IS Pharma licenses episil to Teva

episil is a patented oral spray indicated for local treatment of pain related to oral mucositis. The tie up allows Teva to commercialize episil in Germany, Spain, Poland,